Guru Ownership Trend
Guru Analysis for Fate Therapeutics, Inc. (FATE)
Fate Therapeutics, Inc. (FATE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.16 M.
Top institutional holders include Renaissance Technologies and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $2.61 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Fate Therapeutics, Inc. (FATE)
Major holders include Renaissance Technologies ($2.32 M), Steven Cohen ($1.5 M), Cliff Asness ($1.14 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 5.78 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.61 M, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in FATE during the most recent reporting period.
Yes, 1 managers opened new positions in FATE, and 2 increased their existing holdings. The total reported buy value was $2.61 M.